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Flwrcsccncc quenchiny of lxnxo[cr]pyrcnc (BP) by cytushromc P450 IAl was used ~ci probe the CTTCCI of the lipid. ditruroyl.t3.phoph;li- 
dylcholinc, an Ihis subslrulc-cnrymc inlcrucliun. In ~hc presence of lipid. il monocloF*l nnriboriy IO this P450 muximtilly inhibited BP binding 
UI un antibody-lo-P-450 rrlia al’ t:2. corresponding IO nn untibody craulinkcd P45O complcx, The allibody did not inhibit BP bindinn in lhc 
;lbtincc of lipid. Thcsc rcsuhs indialc tlut when P450 is subjcctcd to the oricnlrlionnt constmintr imposed by unlibody-mcdititd crorstinkin& 
the lipid ;rlirrs ihc canfcxmn!ion or qunnlcrnury siruciurc of the P-450 oligomcr in u milnncr which rhlrnBn itlr u!Itnily for BP. 
Cytachromc P-45& Dikluroyl~~.3.phorpha~idylrholinc; Ucnzo[u]pyrcnc 
1. INTRODUCi’ION 
Tllc cytochromcs P=450 urc u family of hcmcprotcin 
enzymes thut catalyze the oxidation of ;I wide army of 
lipophilic compounds [l-41. Thcsc include xcnobiotics, 
such us drug ond corcinogcns. us well us cndogcnous 
compounds, such PS prostuglundins. fatty acids and 
steroids. The various forms of P-450 difk in their sub- 
strate and product spccificitics and ecactivitics. For the 
polyuromntic hydrocarbon-mcttrbolizina rat liver mi- 
Crosolnul P-450 lAl, binding to the subdtrutc bcn- 
rofcrjpyrcnc (BP) results in cxcitution cncrgy trimsfcr 
from this fluorcticcnt donor to the P-450 IA1 hcmc 
ucccptor. This property has proven useful as u probe for 
BP binding to P-450 IA1 [5-81. 
Expression CIT P-450 catalytic activities i\rc modulntcd 
by P-450 intcructions with csscntiul cofactors such us 
NADPH-dependent cytochromc P-450 rcductusc [9] 
and mcmbrunc lipids [lo]. WC previously utilixd the 
fluorcsccncc quenching rcchniquc to show that the role 
of rcductusc extends beyond that of un clcctron trunsfcr 
ngcnt. since it cnhunccd binding of BP-P-45\) to IA1 [8]. 
WC hnvc now used this rcchniquc to rxtlminc the effect 
of the lipid, diluu~~yl~~-3-pl~osph~tidylcl~olinc (DLPC), 
on the BP-P-450 I Al intcmcrion, and on the rclativc 
orientations of individual P-450 molcculcs. 
2. MATERIALS AND METHODS 
Rot liver nricrosomal P-450 I A I was puriticd from liver microsomcs 
of 3~mclhplcliolrnthrcnc~~rcJtfd mnlc rats ns dcscribcd [8], and its 
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prolcin concentnlion was determined by umino xid rnulysis (pcr- 
farmed by Pcplidc Tahnologier Inc.. Wurhinplon. DC). Monoclonrl 
smibody (MAb) l-7-1 IO P45O I Al [I I] w:s puriticcl from m~uss 
us&es fluid [I?], 
Binding of UP to P-450 IAI wus mcrrurcd by the tluorcsccncc 
quenching tcchniquc. ascnlially us described [S] BP und P450 wcrc 
incub;llcd ut 25’C for 30 min. followed by uddition of DLPC rend 
further incub;ltion for 30 min. When present. MAb f-7-l was prc- 
incubrtcd wilh P450 lAt for 30 min prior to ulddhion of BP. The 
rcvction componcnlr wcrc inhially at about filly-fold their final con- 
ccnlr;ltionw. in 50 mM polossium phospLtc buffer (pll 7.25). 20% 
glycerol. The rcsaion mixlurc *as ihcn diluted to Ihc dcsircd conscn- 
frslion with 0, I M poussium phorphutc buffer (pH 7.25) conrainina 
20% gtyccrot. and fluorcsccncc was immcdirlcty (&cr I .5 min) mar- 
urcd. For kinclic dissocinGon cxpcrimcnlr lhc fluorescence wa: fol- 
lowed for t h, 
Fluorcsccncc wus rncasurcd ut 25% with 1 SLM tloooC photon 
c0untin.g spcc~rofluoromctcr, using previously cstubtishcd condhionr 
[8], Excitation und emission wavclcnglhs wcrc 388 nm and 406 nm, 
rcrpcctivcly. nnd both slit widths were 8 nm. 
3. RESULTS 
The quenching of fluorcsccncc by ths P-450 lmnc 
moiety was used to monitor binding of BP to P450 
1Al. Fluorcsccncc quenching by P-450 1Al is highly 
specific since ncithcr other forms of P-450 [5,8] nor 
apo-P-450 1Al [6] quench BP fluorcsccnce. Quenching 
is also csscntially complete. which facilities data rrnaly- 
sis bccausc the concentration of free BP is proportional 
to observed fluorescence. and the fraclion of bound BP 
is readily calculated from the fluorcsccncc of BP in rhc 
presence and ubscncc of P-450 IA1 [8]. 
The cffcct of DLPC on binding of BP to P-450 1 A 1 
$ 8huwll in Fig. 1. The fiziixkiii Gf bxiid BP 3k.i iiiz 
appreciably change at DLPC conccntrr?tions up to 0.3 
yg/ml, which reprcscnts a tcnmfold molar cxccss of 
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Fig. I. Effect of DLPC on UP binding ICI P-450 LA1. The lrmounl of 
bound DP wus cllrulaIcd from the fluorcscncc of BP in the ubrcnu 
tmd prncnec af P450. us described in Mu~crials und Mc~lrotls. The 
6olulions contuincd 10 nM DP. 50 nM Pd50 IAl und lhc indiclcd 
ilmounls al DLPC in O,I M pot&urn phorphaw buffis (pH 7.3) 
conkrininy 10% ytyccral. 
DLPC over P-450 lA1. Howcvcr, BP binding decreased 
at higher concentrations of DLPC. 
To further dcfmc the intlucncc of lipid on the BP-P- 
450 interaction WC cvirlulrtcd the cffcct of an anti-P-4§0 
1Al monoslonnl antibody (MAb 1-7-l) on BP binding 
in the presence of 0.2 or 15 ~g/tnl of DLPC (Fig. 28). 
In the presence of either concentration of DLPC, the 
binding curves exhibited a minimum correspanding to 
a I:2 molar ratio of MAb to P-450. inhibition by MAb 
l-7-l is specific since WC previously showed that another 
MAb (1-98-l to P-450 2El) has no effect on BP binding 
[8], and that Mab l-7-1 does not alter BP fluorcscsncc 
in the ubscncc of P-450 1Al (data not shown). Fig. 2A 
also shows tluu DLPC was csscnkd for MAb inhibi- 
tion. since the Mob had no effect in the nbscnsc of 
DLPC. 
The cffcct of lipid on the P-450-BP interaction was 
a!so assessed by following the timc-coursc of BP bind- 
ing after dilution of the concentrated mixture of P-450. 
BP and MAb. The cffcct of MAb on the binding curves 
obtained after the longest ime (8 h) arc shown in Fig. 
2B. Thcsc curves arc strikingly diffcrcnt from those at 
zero time (Fig, ?A), as increasing nmounts of MAb 
uniformly increased binding. The transition between the 
binding profilcs in Fig. 2A and B is represented by the 
rc-equilibration kinetics of BP binding, as shown in Fig. 
3. In the absence of MAb (panel A) the diluted cowplcx 
slowly dissociated in both the abscnsc nnd prcvcncc of 
DLPC, however, different BP binding profiles were ob- 
served iu the ~IWWX of various Mab concentrations 
(panels RF). The data firstly shows that in ths abscncc 
of DLPC. addition of increasing amounts of MAb rc- 
duced the rate of BP dissociation, and hcnsc stabiiizcd 
the P-450-l3P complex. In the presence of DLPC, how- 
ever, BP binding slowly (t?, r~ XI min) incrcoscd from its 
initially lower values. The maximal change was cxhib- 
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Pig. 1. Eff~ of MAb 1-7-l OR I~IC BP-P450 IA1 imcraction. The 
reaction mixtures contained 100 nM B-450, ?O nM BP. und dificrcnl 
nmoumrof Mhb. Mcasurcmcnls of DP bindin wccc pcrformcd with- 
OUI DLPC I#), nnd wilh 1 Wrnl DLPC (A) or IS CcgIrnl DLPC (61, 
immcdinIcly (A) and S h (B) af&r dilution of the conccntralcd rompa 
ncnts. 
iced at the MAb:P-450 cquivalcncc ratio of 0.5 (panel 
D), while smnllcr changss wcrc obscrvcd when cithcr 
P-490 or MAb was prcscnr in cxccss (panels 23, C, E, F’), 
in soncorduncc with the data in Fig. ?A. Thcsc timc- 
dcpcndcnt incrcuscs in BP binding show that dilution 
strengthens the BP-P-450 interaction 
4r DISCUSSIQN 
A basic question in enzyme structure-function stud- 
ies concerns the coupling bstwccn the conformation of 
the substrate binding site and binding of functional 
modulators to distal regions of ths protein, In this study 
WC examined the cffcst of one such modulator, DLPC, 
on the BP-P-450 1Al intcraciiun, Lipids sush as DLPC 
exhibit spccilic interactions with P-450, since different 
lipids vary in their Effect on P -450 activities [ 13,141 and 
conformation [ 151, Lipids may also alter P-450 astivitics 
by directly changing F-450 structure, as lipid binding 
has btcn shown to alter the hcmc iron spin cquilihrium 
[16.17]. A critical role of the membrane lipid bilaycr is 
to enhance interaction of the mcmbranc-bound P450 
and NADIWcyior’nrom5 A%% titztx5e iiiokctrks 
u41* 
Another important role of lipids is to provide a hy- 
drophobic milieu for lipophilic substrates near the 
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mcmbranc-bound P-450. WC obscrvcd that increasing 
the lcvcls of DLPC rcsultcd in lower BP binding to 
P-450 (Fig. 1). Dccreuscd binding wus ulso previously 
reported DS tin incrcuse in the apparent K, [5]. Thcsc 
results nay be attributed to lowerin of BD conccntr;r= 
:ion in the lipid environment and increased psrtitioning 
of W from P-450 to DLPC. 
Previous studies using a variety of methods [lo] huvc 
shown that P-450 forms oligomcrs with sizes corrc- 
sponding to hsxemcrs up to octumcrs, and that lipids 
have no effect on oligomcrizution [17-191. WC thus in- 
tcrprct our results with reference to the model in Fig. 
4. which shows the complex of BP with D P-450 oli- 
gomcr (a hcxamcr is shown for illustrtltivc purposss). 
The three columns represent individual f-450 oligomcrs 
associated with 0.0.5 and 1 .O cquiwlcnts of MAb. Since 
MAb-mediated crosslinking necessarily imposes con= 
formational and/or oricntationnl constrnints on the 
crosslinked P-450 moIcculcs, these UPC shown in u dif- 
ferent and more construincd orientation than non- 
crosslinkcd P-450s. 
The top row represents the system in the ubscncc of 
DLFC, Since BP binding was the same ot nil MAb 
concentrations (Fig. ZA), the three spccisr exhibit the 
same BP binding potential. In the prcscncc of DLPC 
(second row), BP binding wus rcducsd for ull three spc- 
tics us BP wus free to partition from P=450 to DLPC, 
and WIRY lowest at P, MAb:P4§0 rsrtio d 0.5 (Fig. 2A). 
Thus minimum binding was observed under conditions 
favoring the bivnlcnt MAb-P-450 complex (center col- 
umn) while excess MAb favors the univalent MAb-P- 
450 complex (right column) whose binding behavior is 
similar to chat of P-450 alone (left column). 
These results thus show that MAb has no intrinsic 
effect on BP binding by f-450 cilhcr in the presence or 
absence of DLPC. The reduction in BP binding by the 
bivulcnt MA&P=450 complex is thus a dirsct consc- 
qucnce of crosslinking, which miry alter P-450 confor- 
motion and/or quaternary structure. The conformation 
may change if crosslinking enhances the interaction bc- 
twccn the proximate P-450 molcculcs uch us to perturb 
their BP binding sites, and crosslinking may impost 
oricnttitional constraints on the individual P-450 mono- 
mcrs within the oliBomcr in a manner that stcrically 
hinders transfer of BP from DLPC to the P-GO binding 
site. DLPC is responsible for the conformational or 
quaternary structural change of P-450, since no rcduc- 
cion in BP binding was observed in its absence. 
Although the model in Fig, 4 shows MAb crosslink- 
ing of P-450 within a complex, intcrcomplcx crosslink- 
ing is nlan poasiblc but less likdy: once rl MAb molecule 
binds one cpitopc within the complex. the second MAb 
binding site is more proximate to an thus more likely to 
&id &ii @JjX iii th StiiX ^aj4!S ZtkZ tk% 23 
cpitopc in another complex. Thus inrmcomplcx cross- 
linking is favored over intercornplex crosslinking. 
The role of DLPC was also examined by changing the 
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Fig. 3. Effcsl of DLPC und MAb I-7.1 on progrc*+limc CUNCS for 
the intcrxlion bctwccn BP and P-450 I A I, The prcezquilibntcd BP- 
P-450 complex was diluted Iil’ty&ld und BP bindin was mcxured, 
Reaction cnndhionr wcrc the stimc US in Fig. 2 rnd were pcrformcxi 
without DLPC (e), und with 2 yglml WLK (A) or I5 p&/ml DLPC 
(a), Mcaaurcmcnts wcrc pcrformcd lhc MAW&450 ratios shown in 
each zilch. 
order of mixing the reaction components. In the MAb 
inhibition cxperimcnts prcscntcd in Fig. 2, MAb was 
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Fig 4, Schcmnfic model of MAb-P.4SOmBP inuractiont. Tbc filled 
circler rcprusn~ UP und the rtrvdcd region rcprcscnlr DLPC mate- 
culcr. The rpcics in rhr three columns rcprcssnt individual P4u) 
otigomcric rpscics ass&& with 0, 0.5 and I .O motccutsx or MAb. 
Top row, con~ptcxa wilhoul DLPC: second row. csrmptcxcs in ltrc 
prcscnrc of DLPC: hallam row. complcxcs after dilution. showing 
dinociu:ion of MAb from P-450. 
cquilibratcd with P-450 prior to addition of DLPC. 
Mowcvcr. if P-450 was mixed with 15 pglml DLPC prior 
to addition of MAb, the inhibition profile at zero time 
did not exhibit a minimum and rescmblcd that in Fig. 
28 (data not shown), Thus bivatcnt MAb-P-450 com- 
plcxcs z~rc only produced in the abscncc of DLPC, 
When DLPC is prcscnt, the orientation of P-450 mono- 
mcrs within the oligomcr is presumably infavorublc for 
bivalcnt MAb binding. 
After the conccntratcd mixture of MAb, P450 and 
BP (second row) is diluted, rc-equilibration occurs (bot- 
tom row). In the abscncc of MAb (left column), BP as 
cxpectcd dissociated from F-450 (Fig. 3, top panel). 
howcvcr. dilution under conditions favoring bivalcnt 
MAb complexes (center column) incrcassd BP binding. 
WC postulate that dilution shifts the equilibria toward 
dissociation of MAb from P-450, which allows a timc- 
dcpcndcnt rclnxation to P.450 contbrmation or quatcr- 
nary structure that more effectively binds BP. The BP 
binding kinetics (Fig. 3) indicate that this process has 
a t:; of about 20 min. A similar time scale was reported 
for changes in catalytic astivity following incubation of 
P-430 TiMi i@i! j28i3. Tfiis iZii& m atZtitis’ i0 a:nr 
changes in P-450-lipid interactions, and muy urisc from 
a lipid.induccd conformational change or reorientation 
of P-450 nwnomcrs, 
WC have thus utilized MAb-mcdiutcd crosslinking us 
a sensitive probe for the cffcct of lipid on P-450 static- 
turc. Our data dcmonstratc that lipid modilics the con- 
formation and/or orientation of P-4505 within the oli- 
gomcr, since MAb could inhibit BP bindina to oligom- 
cric P-450 in the presence of lipid, but hnd no effect 
when added to P-450 in the ;Ibssncs of lipid. Such effects 
on the quaternary structure of P=45Os arc important 
bccrrusc P-450 substrates urc often sequentially mc= 
tubolized by multiple P-450s and the relative orienta- 
tion of P-450s within an oligomcr may alter metabolic 
flow and chc ultimrrtc disposition of P substrate [21]. 
REFERENCES 
[I] Lu. A.Y.H. und %‘a, S.U. (1980) Phzmucot. Rev. 31,277~195, 
I?] Oriix de Munlclluna, P,R, (IQU6) Cy~ochromc P-450: Siruclurc, 
Mcch;urisna nnd Biechcmitiry. Ptcnum Prcu. New York. 
[3] Ryan. D.tZ und Lcvin. W. (1990) Phurmucot. Tbrr. 45. 153-39, 
[4] Ncbcr!. D.W.. Nelson. D.R.. Adcrnik. M.. Caun. M.J.. Enas 
brook. R-W., Fcycrcisca. R.. FujiimKuriy;lm;r. Y,. Gonadcx, F.J., 
Gucngcrich, P.P.. Gunsalur. I.C,, Johnrun. E,F.. Loper, J.C.. 
Suio, R,. Wolcrman. M.R. und Wxnrun, D.J. (1991) DNA IO, 
i-14. 
[S) Mrrea C.B..Turncr. CR. nnd lcfcoulc, C.R. (1915) Biochemir;~ 
try 24. 5115-5123. 
16) Omulu. Y., Ucno, 3’. and Aihurrl, K. (1916) Biechim. Ubplr~, 
Acfn 170. 293100. 
17) Onrulu. Y.. Aibaru. K. und Ucna. Y. (19X7) Uiochim. Biophyr. 
Acfn 912. 11s133. 
[tl) Om;ll;l, Y. ml Fricdmrn, F.K. (1991) Biochcm. Phnrmucot. 42, 
97-101 I 
Pelerrian. J.A. and tJrouyh. R.A. (1916) in: Cy~achromc P4u1, 
S~ruc~urc, Mcchunbm and BirxhcmLry, (Ortiz dc Ma~~~ctt~no. 
P.R., cd.1 pp. I%117. Ptcnum Prcs. New York, 
tnplcmnn&u~dbcr. M. (1916) in: Cylochramc P-450, Slruclurc. 
Mcchanirm and Bioctrcmislry (Orliz Jr Monlctt&na, P.R.. cd,) 
pp. 119-160. Plenum Prcrs. New York. 
Park. S.S.. Fujino. T.. Wcs~, D.. Gucngcrich, F-1’. i111d Gctbain. 
H.V. (IPI Cancer Rcr. 42. 179&l-1808. 
Slunkcr. L,H.. V;mdcrluun, M. und Ju;lrcs&alinrs. It. (1985) J. 
Immunal. Mahods 76. t57- 169. 
Ebcrhart, D.C. and Pnrkinlran. A. (1991) Arch. Biacbsnr. Bia- 
phyr. ?Yt.?3t -140. 
Muttc~Enoclr. LX, Churchill. P., Flcirchcr. S. and Gucnycrich. 
F.P, (tPtt4) t, Biot. Chcm. 159, tit7C81X?. 
Rirtjcnu, I.M.. Anchcr. L.J. und Vccgcr. C. (1919) Eur. 1. Bio- 
chcm. ttl, M9-516. 
Gibson. GG.. Cintl, D,L,, Stiynr. S.G, und Schcnkm;m, J.U. 
(1980) I, Biol, Chcm. 255, 1867-1873, 
Yuny. C.S, und Tsonp. T,Y. (19110) in: Microramcs, Drug Oxida- 
iianw. and Chcmicnl Carcinogcncrir (Coon. M.J., Conncy. A.M.. 
hlabrook. R.W.. Gctboin, t-t.%‘.. GilcIte. J.R. iInd O’Brien, P.J.. 
Cdr.1 pp 199-32, AE;idcmic Prcrr, New York. 
[IX] Gucngcrich. F,P. and Holtuduy, LA. (1979) Biochrmislry tn. 
5442-5449. 
[t9) French. J S.. Gucngcricb. F P. ;III~ Coan. M.J. (1980) J. Biol. 
Chcm. 155, 4111-4119. 
[lo] Cilurcy. K.M., Eycr, C.S, and Buckcs, W.L, (1990)Mol. Phiirma* 
cat. 38, 134-142. 
[?I] Ateon, k.. Robinson, R,C.. Purk, S.S.. Gciboin. H.Y. and Fried- 
I~IIL F.K. (1991) I. Biol. Ctrcm. 166, 735-739. 
252 
